Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ther Umsch ; 78(10): 605-613, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-34844431

RESUMEN

Pancreatic cancer Abstract. Pancreatic cancer is the second most common cancer in the GI tract in Europe and North America and it is associated with a poor prognosis due to its aggressive tumor biology. Each year the number of deaths from pancreatic cancer is almost the same as the number of new cases diagnosed. Most of the pancreatic cancers develop from exocrine cells, while endocrine pancreatic cancers (i. e., neuroendocrine tumors or islet cell tumors) are uncommon. The term "pancreatic cancer" is typically used to refer to pancreatic adenocarcinoma, which will be the focus of this paper. Despite the introduction of multimodal therapy concepts, advanced surgical techniques, and increasing surgical specialization, overall survival in pancreatic cancer has not significantly improved. Early and complete surgical tumor resection remains the only curative option; however, this is rarely achieved, mainly due to the advanced stage at diagnosis. Adjuvant chemotherapy has become the gold standard after upfront resection. Neoadjuvant chemotherapy regimens, such as FOLFIRINOX, represent a valid option in order to achieve complete surgical tumor resection in more advanced cases. However, the overall uptake of this promising concept is very low.


Asunto(s)
Adenocarcinoma , Neoplasias Pancreáticas , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Quimioterapia Adyuvante , Humanos , Terapia Neoadyuvante , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/terapia
2.
Praxis (Bern 1994) ; 109(16): 1276-1279, 2020.
Artículo en Alemán | MEDLINE | ID: mdl-33292014

RESUMEN

Really Just a Side Effect of Capecitabine? Case Report from the Oncological and Neurological Consultation Abstract. A case of our oncology and neurology department is presented. A male patient developed sensory polyneuropathy and mild left-side hemiparesis while receiving neoadjuvant radiochemotherapy with capecitabine as treatment for rectal cancer. Polyneuropathy as a side effect of capecitabine was thought to be the culprit. But upper motor neuron signs were highly supposed to be caused by an acute varicella zoster myelitis, a rare complication of varicella zoster infection possibly facilitated by immunosuppression due to chemotherapy.


Asunto(s)
Herpes Zóster , Mielitis , Capecitabina/efectos adversos , Herpes Zóster/diagnóstico , Herpesvirus Humano 3 , Humanos , Masculino , Derivación y Consulta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...